Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
33%(1 trials)

Phase Distribution

Ph phase_4
4
67%
Ph phase_3
1
17%
Ph not_applicable
1
17%

Phase Distribution

0

Early Stage

0

Mid Stage

5

Late Stage

Phase Distribution6 total trials
Phase 3Large-scale testing
1(16.7%)
Phase 4Post-market surveillance
4(66.7%)
N/ANon-phased studies
1(16.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Completed(3)
Other(3)

Detailed Status

unknown3
Completed3

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 31 (16.7%)
Phase 44 (66.7%)
N/A1 (16.7%)

Trials by Status

unknown350%
completed350%

Recent Activity

0 active trials
Showing 5 of 6
unknownnot_applicable

Zotarolimus vs Sirolimus Eluting Stent in High Bleeding Risk

NCT05240781
completedphase_4

Optimal Duration of Clopidogrel in Second-Generation Drug-Eluting Stents

NCT03056118
completedphase_4

Efficacy of Everolimus-Eluting Versus Zotarolimus-Eluting Sten for Coronary Lesions in Acute Myocardial Infarction

NCT01347554
completedphase_4

Z-SEA-SIDE: Sirolimus Versus Everolimus Versus Zotarolimus-eluting Stent Assessment in Bifurcated Lesions and Clinical SIgnificance of Residual siDE-branch Stenosis

NCT01200693
unknownphase_3

Zotarolimus-eluting Endeavor Sprint Stent in Uncertain DES Candidates (ZEUS) Study

NCT01385319
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT05240781Not Applicable

Zotarolimus vs Sirolimus Eluting Stent in High Bleeding Risk

Unknown
NCT03056118Phase 4

Optimal Duration of Clopidogrel in Second-Generation Drug-Eluting Stents

Completed
NCT01347554Phase 4

Efficacy of Everolimus-Eluting Versus Zotarolimus-Eluting Sten for Coronary Lesions in Acute Myocardial Infarction

Completed
NCT01200693Phase 4

Z-SEA-SIDE: Sirolimus Versus Everolimus Versus Zotarolimus-eluting Stent Assessment in Bifurcated Lesions and Clinical SIgnificance of Residual siDE-branch Stenosis

Completed
NCT01385319Phase 3

Zotarolimus-eluting Endeavor Sprint Stent in Uncertain DES Candidates (ZEUS) Study

Unknown
NCT01133925Phase 4

Optical Coherence Tomography in Long Lesions

Unknown

All 6 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
6